Cannabidiol (CBD) oil is rapidly shifting from fringe remedy to everyday wellness staple, driven by a mix of emerging science, regulatory change and word-of-mouth testimony. Unlike tetrahydrocannabinol (THC), CBD does not produce a psychoactive “high,” a distinction that researchers, journalists and educators have worked to clarify for the public. Early studies suggest potential benefits for anxiety, inflammation and sleep, encouraging consumers to explore CBD as an alternative or complement to conventional treatments.​

Growing legal recognition of non-intoxicating CBD, along with clearer rules for its sale, has expanded research and market access in many regions. At the same time, reputable brands now highlight transparent sourcing and third-party lab testing, helping users distinguish quality products from dubious offerings. As The Assam Tribune reports, this evidence-led, cautiously optimistic approach—balancing curiosity with skepticism—is at the heart of CBD’s rising credibility in global wellness culture. You can read the original article at The Assam Tribune.